Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Journal for Immunotherapy of Cancer
|
February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2023
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
Annapaola Mariniello, Tahseen H Nasti, Daniel Y Chang, et al.
Journal for Immunotherapy of Cancer
|
July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
Marta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Nature Medicine
|
April 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial
Ignacio Melero, Tamara Tanos, Emiliano Calvo Aller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2024
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Solange Peters, Eric Angevin, Teresa Alonso-Gordoa, et al.
The Journal of Clinical Investigation
|
May 23, 2023
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
Benedetta Apollonio, Filomena Spada, Nedyalko Petrov, et al.
Cancer Research
|
May 16, 2020
The PET-Tracer <sup>89</sup>Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
Christoph M Griessinger, Tove Olafsen, Alessandro Mascioni, et al.
Science Translational Medicine
|
October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatment
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Journal for Immunotherapy of Cancer
|
February 11, 2025
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
Eneko Garate-Soraluze, Irantzu Serrano-Mendioroz, Leticia Fernández-Rubio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2023
Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade
Annapaola Mariniello, Tahseen H Nasti, Daniel Y Chang, et al.
Journal for Immunotherapy of Cancer
|
July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
Marta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Nature Medicine
|
April 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial
Ignacio Melero, Tamara Tanos, Emiliano Calvo Aller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2024
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Solange Peters, Eric Angevin, Teresa Alonso-Gordoa, et al.
The Journal of Clinical Investigation
|
May 23, 2023
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
Benedetta Apollonio, Filomena Spada, Nedyalko Petrov, et al.
Cancer Research
|
May 16, 2020
The PET-Tracer <sup>89</sup>Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
Christoph M Griessinger, Tove Olafsen, Alessandro Mascioni, et al.
Science Translational Medicine
|
October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatment
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Page
of 5